Neovacs amends IPO

Neovacs S.A., Paris, France Business: Autoimmune, Inflammation, Cancer Date announced: 4/9/10 Type: IPO To be raised: About €11 million ($14.8 million) Shares: 2.3 million Price: €4.80-€5.60 Overallot...